Table 5 Comparison of unadjusted ten-year oncologic survival outcomes between men with a delayed detectable PSA for 3348 patients who underwent radical prostatectomy at University of California, San Francisco.
From: The natural history of a delayed detectable PSA after radical prostatectomy
Outcome | Salvage Treatment | ||
|---|---|---|---|
Yes | No | p-value | |
Metastasis-free survival | 86% | 97% | <0.01 |
Prostate cancer-specific mortality | 5% | 1% | 0.05 |
All-cause mortality | 7% | 5% | 0.53 |
